The Drug Controller General of India (DCGI) has approved application of five companies to begin production of antifungal drug Amphotericin B liposomal injection, which is critical in the treatment of Mucormycosis, also called 'Black Fungus'.
The five companies that got permission to manufacture are Natco Pharma, Gufic Biosciences, Alembic Pharmaceuticals, Emcure Pharmaceuticals and Lyca Pharmaceuticals.
Currently six companies are manufacturing the drug these include Mylan, Bharat Serums and Vaccines, BDR Pharma, Sun Pharma, Cipla and Life Care.
"The existing pharma companies have already started ramping up the production.
Indian Companies have also placed orders for importing 6 lakh vials of AmphotericinB," said Minister of State for Chemicals and Fertilisers Mansukh Mandaviya.
"We are leaving no stone unturned to smoothen the situation," Mandaviya said.
Please read here how the companies are scrambling to expand capacities.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
